Prevalence and descriptive epidemiology of Turner syndrome in the United States, 2000-2017: A report from the National Birth Defects Prevention Network
- PMID: 36919524
- PMCID: PMC10405780
- DOI: 10.1002/ajmg.a.63181
Prevalence and descriptive epidemiology of Turner syndrome in the United States, 2000-2017: A report from the National Birth Defects Prevention Network
Abstract
The lack of United States population-based data on Turner syndrome limits assessments of prevalence and associated characteristics for this sex chromosome abnormality. Therefore, we collated 2000-2017 data from seven birth defects surveillance programs within the National Birth Defects Prevention Network. We estimated the prevalence of karyotype-confirmed Turner syndrome diagnosed within the first year of life. We also calculated the proportion of cases with commonly ascertained birth defects, assessed associations with maternal and infant characteristics using prevalence ratios (PR) with 95% confidence intervals (CI), and estimated survival probability. The prevalence of Turner syndrome of any pregnancy outcome was 3.2 per 10,000 female live births (95% CI = 3.0-3.3, program range: 1.0-10.4), and 1.9 for live birth and stillbirth (≥20 weeks gestation) cases (95% CI = 1.8-2.1, program range: 0.2-3.9). Prevalence was lowest among cases born to non-Hispanic Black women compared to non-Hispanic White women (PR = 0.5, 95% CI = 0.4-0.6). Coarctation of the aorta was the most common defect (11.6% of cases), and across the cohort, individuals without hypoplastic left heart had a five-year survival probability of 94.6%. The findings from this population-based study may inform surveillance practices, prenatal counseling, and diagnosis. We also identified racial and ethnic disparities in prevalence, an observation that warrants further investigation.
Keywords: Turner syndrome; birth defects; epidemiology; prevalence; sex chromosome abnormality.
© 2023 Wiley Periodicals LLC.
Conflict of interest statement
CONFLICT OF INTEREST STATEMENT
The authors have no relevant conflicts of interest.
References
-
- Berglund A, Viuff MH, Skakkebæk A, Chang S, Stochholm K, & Gravholt CH (2019). Changes in the cohort composition of turner syndrome and severe non-diagnosis of Klinefelter, 47,XXX and 47,XYY syndrome: A nationwide cohort study. Orphanet Journal of Rare Diseases, 14(1), 16. 10.1186/s13023-018-0976-2 - DOI - PMC - PubMed
-
- Buckway CK, Magenis RE, Bissonnette JM, Olson S, & Rosenfeld RG (2000). Prenatal diagnosis of turner syndrome: The Portland experience. In Saenger P & Pasquino AM (Eds.), Optimizing health care for Turner patients in the 21st century: Proceedings of the 5th international turner symposium held in Naples on 23–25 March 2000, (p. 336). Elsevier Science.
-
- Canfield MA, Honein MA, Yuskiv N, Xing J, Mai CT, Collins JS, Devine O, Petrini J, Ramadhani TA, Hobbs CA, & Kirby RS (2006). National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999–2001. Birth Defects Research. Part A, Clinical and Molecular Teratology, 76(11), 747–756. 10.1002/bdra.20294 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
